- Home
- PAA vs PCVX Comparison
PAA vs PCVX Comparison
Compare PAA & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAA
- PCVX
- Stock Information
- Founded
- PAA 1981
- PCVX 2013
- Country
- PAA United States
- PCVX United States
- Employees
- PAA N/A
- PCVX N/A
- Industry
- PAA Natural Gas Distribution
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PAA Energy
- PCVX Health Care
- Exchange
- PAA Nasdaq
- PCVX Nasdaq
- Market Cap
- PAA 11.4B
- PCVX 13.2B
- IPO Year
- PAA 1998
- PCVX 2020
- Fundamental
- Price
- PAA $17.56
- PCVX $85.96
- Analyst Decision
- PAA Buy
- PCVX Strong Buy
- Analyst Count
- PAA 9
- PCVX 7
- Target Price
- PAA $20.22
- PCVX $147.50
- AVG Volume (30 Days)
- PAA 3.7M
- PCVX 1.5M
- Earning Date
- PAA 11-08-2024
- PCVX 11-05-2024
- Dividend Yield
- PAA 7.24%
- PCVX N/A
- EPS Growth
- PAA N/A
- PCVX N/A
- EPS
- PAA 1.12
- PCVX N/A
- Revenue
- PAA $50,369,000,000.00
- PCVX N/A
- Revenue This Year
- PAA $7.34
- PCVX N/A
- Revenue Next Year
- PAA $4.35
- PCVX N/A
- P/E Ratio
- PAA $15.63
- PCVX N/A
- Revenue Growth
- PAA 2.87
- PCVX N/A
- 52 Week Low
- PAA $14.46
- PCVX $48.24
- 52 Week High
- PAA $19.17
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- PAA 57.08
- PCVX 22.90
- Support Level
- PAA $16.80
- PCVX $84.52
- Resistance Level
- PAA $17.50
- PCVX $88.17
- Average True Range (ATR)
- PAA 0.38
- PCVX 5.21
- MACD
- PAA 0.08
- PCVX -2.10
- Stochastic Oscillator
- PAA 72.63
- PCVX 4.57
About PAA Plains All American Pipeline L.P.
Plains All American provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. Plains' assets span the United States and Alberta, Canada, but are heavily concentrated in the Permian Basin.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.